Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Agranulocytosis after addition of risperidone to clozapine treatment.

Godleski LS, Sernyak MJ.

Am J Psychiatry. 1996 May;153(5):735-6. No abstract available.

PMID:
8615431
2.

Risperidone augmentation of clozapine: a critical review.

Kontaxakis VP, Ferentinos PP, Havaki-Kontaxaki BJ, Paplos KG, Pappa DA, Christodoulou GN.

Eur Arch Psychiatry Clin Neurosci. 2006 Sep;256(6):350-5. Epub 2006 Aug 8. Review.

PMID:
16900439
3.

Clozapine: a novel antipsychotic.

Buch DL.

Am Fam Physician. 1992 Feb;45(2):795-9. Review.

PMID:
1739062
4.

Adjunctive treatment with risperidone in clozapine-resistant schizophrenia: a case report and review.

Lerma-Carrillo I, Molina JD, Cuevas-Durán T, González-Parra S, Blasco-Fontecilla H, Andrade-Rosa C, López-Muñoz F, Alamo C.

Clin Neuropharmacol. 2007 Mar-Apr;30(2):114-21. Review.

PMID:
17414944
5.

Atypical antipsychotic drugs: Part 1.

Keltner NL, Coffeen H, Johnson JE.

Perspect Psychiatr Care. 2000 Jul-Sep;36(3):101-4. Review. No abstract available.

PMID:
11111596
6.

Clinical profile of clozapine: adverse reactions and agranulocytosis.

Lieberman JA, Safferman AZ.

Psychiatr Q. 1992 Spring;63(1):51-70. Review.

PMID:
1438605
7.

Management of treatment-resistant patients with schizophrenia.

Marder SR.

J Clin Psychiatry. 1996;57 Suppl 11:26-30. Review.

PMID:
8941168
8.

The treatment of psychosis in late life.

Zayas EM, Grossberg GT.

J Clin Psychiatry. 1998;59 Suppl 1:5-10; discussion 11-2. Review.

9.

Schizophrenia, violence, clozapine and risperidone: a review. The Special Hospitals Treatment Resistant Schizophrenia Research Group.

[No authors listed]

Br J Psychiatry Suppl. 1996 Dec;(31):21-30. Review. No abstract available.

PMID:
8968652
10.

Clozapine-induced agranulocytosis and its genetic determinants.

Opgen-Rhein C, Dettling M.

Pharmacogenomics. 2008 Aug;9(8):1101-11. doi: 10.2217/14622416.9.8.1101. Review.

PMID:
18681784
11.

Clozapine--a perspective. Accepted as a consensus statement by the ACNP Council, August 13, 1990.

Shader RI.

Neuropsychopharmacology. 1991 Feb;4(2):151-2. Review. No abstract available.

PMID:
2025380
12.

Mechanisms of clozapine-induced agranulocytosis.

Gerson SL, Meltzer H.

Drug Saf. 1992;7 Suppl 1:17-25. Review.

PMID:
1503673
13.

Clozapine: benefits and risks.

Green AI, Salzman C.

Hosp Community Psychiatry. 1990 Apr;41(4):379-80. Review. No abstract available.

PMID:
2158938
14.

Leponex--associated granulocytopenia: a review of the situation.

Krupp P, Barnes P.

Psychopharmacology (Berl). 1989;99 Suppl:S118-21. Review. No abstract available.

PMID:
2682727

Supplemental Content

Support Center